Product Description
Product Name: Reditux 600 mg Injection
Active Ingredient: Rituximab
Strength: 600 mg
Form: Concentrate for Intravenous Infusion
Category: Monoclonal Antibody / CD20-Directed Cytolytic Antibody
Indication: Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA)
Reditux 600 mg Injection contains Rituximab, a CD20-targeting monoclonal antibody used in the treatment of B-cell malignancies and select autoimmune disorders. It is indicated for patients with non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and ANCA-associated vasculitis, including granulomatosis with polyangiitis and microscopic polyangiitis.
